$WVE insider trading
Over the last 12 months, Wave Life Sciences insiders reported 3 buys totaling $82.6M and 19 sales totaling $16.2M across SEC Form 4 filings. 68% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $82.6M 3 events
- Sold · 12m
- $16.2M 19 events
- Events · 12m
- 22 Form 4 filings, grouped
- Insiders · 12m
- 13 distinct reporters
- 10b5-1 share
- 68% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Rawcliffe AdrianD | ▼ Sale | 12,700 | $5.29 | $67K | -100% | plan |
| Aug 11, 2026 | Wagner Heidi LD | ▼ Sale | 7,000 | $6.01 | $42K | -13.5% | plan |
| Aug 11, 2026 | TAKANASHI KEND | ▼ Sale | 3,864 | $6.01 | $23K | -16.1% | plan |
| Aug 11, 2026 | Tan Aik NaD | ▼ Sale | 432 | $6.01 | $3K | -1.7% | plan |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▲ Buy | 8,772,496 | $6.23 | $54.6M | +48.2% | 4 tranches · indirect |
| Feb 26, 2026 | Francis ChrisSee Remarks · O | ▼ Sale | 33,194 | $15.05 | $500K | -34.9% | plan · 2 tranches |
| Feb 9, 2026 | Moran KyleChief Financial Officer · O | ▼ Sale | 3,588 | $13.45 | $48K | -2.6% | — |
| Feb 9, 2026 | BOLNO PAULPresident and CEO · O·D | ▼ Sale | 10,480 | $13.45 | $141K | -3.7% | — |
| Feb 9, 2026 | Francis ChrisSee Remarks · O | ▼ Sale | 1,883 | $13.45 | $25K | -3% | — |
| Feb 9, 2026 | Vargeese ChandraSee Remarks · O | ▼ Sale | 3,228 | $13.45 | $43K | -0.8% | — |
| Jan 2, 2026 | Francis ChrisSee Remarks · O | ▼ Sale | 9,375 | $16.03 | $150K | -27.3% | plan · 2 tranches |
| Dec 11, 2025 | GSK plc10% | ▲ Buy | 1,470,000 | $19 | $27.9M | +8.8% | indirect |
| Dec 9, 2025 | Moran KyleChief Financial Officer · O | ▼ Sale | 260,036 | $15.78 | $4.1M | -74.2% | plan · 6 tranches |
| Dec 8, 2025 | Rawcliffe AdrianD | ▼ Sale | 42,000 | $15 | $630K | -76.8% | plan |
| Dec 8, 2025 | Wagner Heidi LD | ▼ Sale | 14,000 | $13.5 | $189K | -23.8% | plan · 2 tranches |
| Dec 8, 2025 | HENRY CHRISTIAN OD | ▼ Sale | 93,445 | $14.65 | $1.4M | -88% | plan · 4 tranches |
| Dec 8, 2025 | Tan Aik NaD | ▼ Sale | 134,218 | $13.58 | $1.8M | -84.1% | plan · 8 tranches |
| Dec 8, 2025 | Verdine Gregory L.D | ▼ Sale | 20,000 | $13.47 | $269K | -6.8% | plan · 2 tranches |
| Dec 8, 2025 | Francis ChrisSee Remarks · O | ▼ Sale | 441,031 | $14.57 | $6.4M | -94.6% | plan · 9 tranches |
| Dec 8, 2025 | CORRIGAN MARKD | ▼ Sale | 16,115 | $13.48 | $217K | -35.9% | plan · 2 tranches |
| Nov 13, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▲ Buy | 1,000 | $6.69 | $7K | — | indirect |
| Nov 13, 2025 | Rawcliffe AdrianD | ▼ Sale | 16,115 | $6.79 | $109K | -55.9% | plan |
| Aug 22, 2025 | Verdine Gregory L.D | ▼ Sale | 10,000 | $10 | $100K | -3.4% | plan |
| Aug 22, 2025 | BOLNO PAULPresident and CEO · O·D | ▼ Sale | 217,351 | $10.1 | $2.2M | -64.2% | plan |
| Aug 15, 2025 | Tan Aik NaD | ▼ Sale | 21,000 | $9.25 | $194K | -34.2% | plan |
| Aug 13, 2025 | HENRY CHRISTIAN OD | ▼ Sale | 9,670 | $8.81 | $85K | -24.6% | plan |
Every $WVE filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Wave Life Sciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $WVE feed.